Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 46.30
+0.15 (0.33%)
Oct 31, 2025, 1:21 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 4.02 billion as of October 31, 2025. Its market cap has decreased by -7.95% in one year.
Market Cap
4.02B
Enterprise Value
6.28B
Revenue
4.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
46.30
Market Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 4.02B, an increase of 473.11%. That is a compound annual growth rate of 8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 4.02B | -3.94% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | 4.17B | -13.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |